Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence

Meera Nanjundan, Lauren Averett Byers, Mark S. Carey, Doris R. Siwak, Maria Gabriela Raso, Lixia Diao, Jing Wang, Kevin R. Coombes, Jack A. Roth, Gordon Mills, Ignacio I. Wistuba, John D. Minna, John V. Heymach

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is an important step toward understanding lung pathogenesis and developing new therapeutic approaches. Methods: Toward this goal, reverse-phase protein lysate arrays (RPPA) were used to compare signaling pathways between NSCLC tumors and paired normal lung tissue from 46 patients and assess their association with clinical outcome. Results: After RPPA quantification of 63 proteins and phosphoproteins, tissue pairs were randomized to a training set (n = 25 pairs) and test set (n = 21 pairs). In the training set, 15 protein markers were differentially expressed between tumors and normal lung (p ≤ 0.01), including markers in the PI3K/AKT and p38 MAPK signaling pathways (e.g., p70S6K, S6, p38, and phospho-p38), as well as caveolin-1 and β-catenin. A four-protein signature (p70S6K, cyclin B1, pSrc(Y527), and caveolin-1) independent of histology classified specimens as tumor versus normal with a predicted accuracy of 83%, sensitivity of 67%, and specificity of 100%. The signature was validated in the test set, correctly classifying all normal tissues and 14 of 21 tumor tissues. RPPA results were confirmed by immunohistochemistry for caveolin-1 and p70S6K. In tumors from patients with resected NSCLC, expression of proteins in the energy-sensing AMPK pathway (pLKB1, AMPK, p-Acetyl-CoA, pTSC2), adhesion, EGFR, and Rb signaling pathways was inversely associated with NSCLC recurrence. Conclusions: These data provide evidence for dysregulation of several pathways including those involving energy sensing and adhesion that are potentially associated with NSCLC pathogenesis and disease recurrence.

Original languageEnglish (US)
Pages (from-to)1894-1904
Number of pages11
JournalJournal of Thoracic Oncology
Volume5
Issue number12
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

AMP-Activated Protein Kinases
Non-Small Cell Lung Carcinoma
Proteomics
70-kDa Ribosomal Protein S6 Kinases
Caveolin 1
Protein Array Analysis
Recurrence
Neoplasms
Lung
Proteins
Cyclin B1
S 6
Catenins
Acetyl Coenzyme A
Phosphoproteins
p38 Mitogen-Activated Protein Kinases
Phosphatidylinositol 3-Kinases
Lung Diseases
Histology
Immunohistochemistry

Keywords

  • Adhesion
  • AMPK
  • NSCLC
  • Proteomics
  • Recurrence

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence. / Nanjundan, Meera; Byers, Lauren Averett; Carey, Mark S.; Siwak, Doris R.; Raso, Maria Gabriela; Diao, Lixia; Wang, Jing; Coombes, Kevin R.; Roth, Jack A.; Mills, Gordon; Wistuba, Ignacio I.; Minna, John D.; Heymach, John V.

In: Journal of Thoracic Oncology, Vol. 5, No. 12, 01.01.2010, p. 1894-1904.

Research output: Contribution to journalArticle

Nanjundan, M, Byers, LA, Carey, MS, Siwak, DR, Raso, MG, Diao, L, Wang, J, Coombes, KR, Roth, JA, Mills, G, Wistuba, II, Minna, JD & Heymach, JV 2010, 'Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence', Journal of Thoracic Oncology, vol. 5, no. 12, pp. 1894-1904. https://doi.org/10.1097/JTO.0b013e3181f2a266
Nanjundan, Meera ; Byers, Lauren Averett ; Carey, Mark S. ; Siwak, Doris R. ; Raso, Maria Gabriela ; Diao, Lixia ; Wang, Jing ; Coombes, Kevin R. ; Roth, Jack A. ; Mills, Gordon ; Wistuba, Ignacio I. ; Minna, John D. ; Heymach, John V. / Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence. In: Journal of Thoracic Oncology. 2010 ; Vol. 5, No. 12. pp. 1894-1904.
@article{bbca63ba80314eaab5bfe1ca9195134b,
title = "Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence",
abstract = "The identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is an important step toward understanding lung pathogenesis and developing new therapeutic approaches. Methods: Toward this goal, reverse-phase protein lysate arrays (RPPA) were used to compare signaling pathways between NSCLC tumors and paired normal lung tissue from 46 patients and assess their association with clinical outcome. Results: After RPPA quantification of 63 proteins and phosphoproteins, tissue pairs were randomized to a training set (n = 25 pairs) and test set (n = 21 pairs). In the training set, 15 protein markers were differentially expressed between tumors and normal lung (p ≤ 0.01), including markers in the PI3K/AKT and p38 MAPK signaling pathways (e.g., p70S6K, S6, p38, and phospho-p38), as well as caveolin-1 and β-catenin. A four-protein signature (p70S6K, cyclin B1, pSrc(Y527), and caveolin-1) independent of histology classified specimens as tumor versus normal with a predicted accuracy of 83{\%}, sensitivity of 67{\%}, and specificity of 100{\%}. The signature was validated in the test set, correctly classifying all normal tissues and 14 of 21 tumor tissues. RPPA results were confirmed by immunohistochemistry for caveolin-1 and p70S6K. In tumors from patients with resected NSCLC, expression of proteins in the energy-sensing AMPK pathway (pLKB1, AMPK, p-Acetyl-CoA, pTSC2), adhesion, EGFR, and Rb signaling pathways was inversely associated with NSCLC recurrence. Conclusions: These data provide evidence for dysregulation of several pathways including those involving energy sensing and adhesion that are potentially associated with NSCLC pathogenesis and disease recurrence.",
keywords = "Adhesion, AMPK, NSCLC, Proteomics, Recurrence",
author = "Meera Nanjundan and Byers, {Lauren Averett} and Carey, {Mark S.} and Siwak, {Doris R.} and Raso, {Maria Gabriela} and Lixia Diao and Jing Wang and Coombes, {Kevin R.} and Roth, {Jack A.} and Gordon Mills and Wistuba, {Ignacio I.} and Minna, {John D.} and Heymach, {John V.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1097/JTO.0b013e3181f2a266",
language = "English (US)",
volume = "5",
pages = "1894--1904",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "12",

}

TY - JOUR

T1 - Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence

AU - Nanjundan, Meera

AU - Byers, Lauren Averett

AU - Carey, Mark S.

AU - Siwak, Doris R.

AU - Raso, Maria Gabriela

AU - Diao, Lixia

AU - Wang, Jing

AU - Coombes, Kevin R.

AU - Roth, Jack A.

AU - Mills, Gordon

AU - Wistuba, Ignacio I.

AU - Minna, John D.

AU - Heymach, John V.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is an important step toward understanding lung pathogenesis and developing new therapeutic approaches. Methods: Toward this goal, reverse-phase protein lysate arrays (RPPA) were used to compare signaling pathways between NSCLC tumors and paired normal lung tissue from 46 patients and assess their association with clinical outcome. Results: After RPPA quantification of 63 proteins and phosphoproteins, tissue pairs were randomized to a training set (n = 25 pairs) and test set (n = 21 pairs). In the training set, 15 protein markers were differentially expressed between tumors and normal lung (p ≤ 0.01), including markers in the PI3K/AKT and p38 MAPK signaling pathways (e.g., p70S6K, S6, p38, and phospho-p38), as well as caveolin-1 and β-catenin. A four-protein signature (p70S6K, cyclin B1, pSrc(Y527), and caveolin-1) independent of histology classified specimens as tumor versus normal with a predicted accuracy of 83%, sensitivity of 67%, and specificity of 100%. The signature was validated in the test set, correctly classifying all normal tissues and 14 of 21 tumor tissues. RPPA results were confirmed by immunohistochemistry for caveolin-1 and p70S6K. In tumors from patients with resected NSCLC, expression of proteins in the energy-sensing AMPK pathway (pLKB1, AMPK, p-Acetyl-CoA, pTSC2), adhesion, EGFR, and Rb signaling pathways was inversely associated with NSCLC recurrence. Conclusions: These data provide evidence for dysregulation of several pathways including those involving energy sensing and adhesion that are potentially associated with NSCLC pathogenesis and disease recurrence.

AB - The identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is an important step toward understanding lung pathogenesis and developing new therapeutic approaches. Methods: Toward this goal, reverse-phase protein lysate arrays (RPPA) were used to compare signaling pathways between NSCLC tumors and paired normal lung tissue from 46 patients and assess their association with clinical outcome. Results: After RPPA quantification of 63 proteins and phosphoproteins, tissue pairs were randomized to a training set (n = 25 pairs) and test set (n = 21 pairs). In the training set, 15 protein markers were differentially expressed between tumors and normal lung (p ≤ 0.01), including markers in the PI3K/AKT and p38 MAPK signaling pathways (e.g., p70S6K, S6, p38, and phospho-p38), as well as caveolin-1 and β-catenin. A four-protein signature (p70S6K, cyclin B1, pSrc(Y527), and caveolin-1) independent of histology classified specimens as tumor versus normal with a predicted accuracy of 83%, sensitivity of 67%, and specificity of 100%. The signature was validated in the test set, correctly classifying all normal tissues and 14 of 21 tumor tissues. RPPA results were confirmed by immunohistochemistry for caveolin-1 and p70S6K. In tumors from patients with resected NSCLC, expression of proteins in the energy-sensing AMPK pathway (pLKB1, AMPK, p-Acetyl-CoA, pTSC2), adhesion, EGFR, and Rb signaling pathways was inversely associated with NSCLC recurrence. Conclusions: These data provide evidence for dysregulation of several pathways including those involving energy sensing and adhesion that are potentially associated with NSCLC pathogenesis and disease recurrence.

KW - Adhesion

KW - AMPK

KW - NSCLC

KW - Proteomics

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=78650494605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650494605&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e3181f2a266

DO - 10.1097/JTO.0b013e3181f2a266

M3 - Article

C2 - 21124077

AN - SCOPUS:78650494605

VL - 5

SP - 1894

EP - 1904

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 12

ER -